Detalles de la búsqueda
1.
Cognitive Changes After Adjuvant Treatment in Older Adults with Early-Stage Breast Cancer.
Oncologist
; 24(1): 62-68, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29934409
2.
Decline in Cognitive Function in Older Adults With Early-Stage Breast Cancer After Adjuvant Treatment.
Oncologist
; 21(11): 1337-1348, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-27473044
3.
Short report: Monitoring ESR1 mutations by circulating tumor DNA in aromatase inhibitor resistant metastatic breast cancer.
Int J Cancer
; 137(10): 2513-9, 2015 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25994408
4.
High-throughput pharmacogenetics identifies SLCO1A2 polymorphisms as candidates to elucidate the risk of febrile neutropenia in the breast cancer RAPP-01 trial.
Breast Cancer Res Treat
; 153(2): 383-9, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26318989
5.
Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial.
Lancet Oncol
; 15(11): 1269-78, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25273342
6.
Extended benefit from sequential administration of docetaxel after standard fluorouracil, epirubicin, and cyclophosphamide regimen for node-positive breast cancer: the 8-year follow-up results of the UNICANCER-PACS01 trial.
Oncologist
; 17(7): 900-9, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22610153
7.
Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6×FEC versus 3×FEC/3×Docetaxel.
BMC Cancer
; 11: 140, 2011 Apr 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-21496284
8.
Prospective analysis of the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-based therapy in metastatic breast cancer patients.
Br J Clin Pharmacol
; 71(6): 921-8, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21204912
9.
Randomised phase II trial evaluating the safety of peripherally inserted catheters versus implanted port catheters during adjuvant chemotherapy in patients with early breast cancer.
Eur J Cancer
; 126: 116-124, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31931269
10.
Clinical improvement and survival in breast cancer leptomeningeal metastasis correlate with the cytologic response to intrathecal chemotherapy.
J Neurooncol
; 95(3): 421-426, 2009 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-19557501
11.
Individualized Prediction of Menses Recovery After Chemotherapy for Early-stage Breast Cancer: A Nomogram Developed From UNICANCER PACS04 and PACS05 Trials.
Clin Breast Cancer
; 19(1): 63-70, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30241966
12.
Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial.
J Clin Oncol
; 37(2): 105-114, 2019 01 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30475668
13.
CXCR4 membrane expression in node-negative breast cancer.
Breast J
; 14(3): 268-74, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18373506
14.
Kinetics, prognostic and predictive values of ESR1 circulating mutations in metastatic breast cancer patients progressing on aromatase inhibitor.
Oncotarget
; 7(46): 74448-74459, 2016 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27801670
15.
Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin, as adjuvant therapy for node-positive breast cancer: French adjuvant study group.
J Clin Oncol
; 22(15): 3070-9, 2004 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-15284257
16.
Reliability of Prognostic and Predictive Factors Evaluated by Needle Core Biopsies of Large Breast Invasive Tumors.
Am J Clin Pathol
; 144(4): 555-62, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26386076
17.
[Bevacizumab and taxanes in the first-line treatment of metastatic breast cancer : overall survival and subgroup analyses of the ATHENA study in France]. / Bévacizumab et taxanes dans le traitement de première ligne du cancer du sein métastatique : survie globale et analyse de sous-groupes de l'étude ATHENA France.
Bull Cancer
; 101(9): 780-8, 2014 Sep.
Artículo
en Francés
| MEDLINE | ID: mdl-25295737
18.
Baseline cognitive functions among elderly patients with localised breast cancer.
Eur J Cancer
; 50(13): 2181-9, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24958735
19.
A higher body mass index and fat mass are factors predictive of docetaxel dose intensity.
Anticancer Res
; 33(12): 5655-62, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24324113
20.
[Safety and efficacy of bevacizumab combined with taxanes in the first-line treatment of metastatic breast cancer: ATHENA study-France]. / Tolérance et efficacité du bévacizumab en association aux taxanes en première ligne dans le cancer du sein métastatique : étude ATHENA-France.
Bull Cancer
; 99(6): 609-18, 2012 Jun.
Artículo
en Francés
| MEDLINE | ID: mdl-22665515